What is Big Think?  

We are Big Idea Hunters…

We live in a time of information abundance, which far too many of us see as information overload. With the sum total of human knowledge, past and present, at our fingertips, we’re faced with a crisis of attention: which ideas should we engage with, and why? Big Think is an evolving roadmap to the best thinking on the planet — the ideas that can help you think flexibly and act decisively in a multivariate world.

A word about Big Ideas and Themes — The architecture of Big Think

Big ideas are lenses for envisioning the future. Every article and video on bigthink.com and on our learning platforms is based on an emerging “big idea” that is significant, widely relevant, and actionable. We’re sifting the noise for the questions and insights that have the power to change all of our lives, for decades to come. For example, reverse-engineering is a big idea in that the concept is increasingly useful across multiple disciplines, from education to nanotechnology.

Themes are the seven broad umbrellas under which we organize the hundreds of big ideas that populate Big Think. They include New World Order, Earth and Beyond, 21st Century Living, Going Mental, Extreme Biology, Power and Influence, and Inventing the Future.

Big Think Features:

12,000+ Expert Videos


Browse videos featuring experts across a wide range of disciplines, from personal health to business leadership to neuroscience.

Watch videos

World Renowned Bloggers


Big Think’s contributors offer expert analysis of the big ideas behind the news.

Go to blogs

Big Think Edge


Big Think’s Edge learning platform for career mentorship and professional development provides engaging and actionable courses delivered by the people who are shaping our future.

Find out more
With rendition switcher


Question: What has been your most exciting discovery?

Shelley des Etages:  The thing I remember the most is we did several experiments with cell lines, with blood cells taken from x-febil [ph?], we call it.  You take the blood cells out and you culture them in a dish and you work with them.  We had done four different experiments, two in vivo, two in vitro.  And I'd analyzed that data, and I'd looked in the literature and looked at genes that change when people are rejecting organs and looking at all these test molecules that we had.  And there was this convergence that there were a couple of genes that we saw in all of our models that changed.  And when I looked in the literature, they were changing in the opposite direction.  So in the transplant scenario, their expression level was going up, and in our models with our test drugs the expression level was going down.  That was a very exciting moment, because I thought, "This is really cool!  I think I have something!"  And I got on the phone, and I called my colleague over in the therapeutic area.  "I think I have something.  I've got something!  This looks very promising.  This looks really good.  We've got to test it."  And I think that was a very exciting moment.

Recorded on: 06/25/2008


The Thrill of Discovery

Newsletter: Share: